Ruxolitinib cost?

Ruxolitinib cost varies a lot by country, dosing, and how you pay (insurance, discounts, patient assistance). Here’s the gist:

- In the United States: Ruxolitinib (brand name Jakafi) is very expensive. The list price is high and the actual out-of-pocket cost depends on your insurance plan, deductible, and copays. Without insurance, monthly costs can be substantial and often amount to thousands to tens of thousands of dollars per month, depending on the dose. With insurance and/or manufacturer assistance, the out-of-pocket can be much lower, but variability is high. I can give a closer estimate if you share your dose and country.

- In other countries: Prices are often lower after national pricing negotiations or subsidies, but they still tend to be expensive for a specialty drug.

If you want a closer estimate, tell me:
- Your country
- The prescribed dose (for example, mg per day and how many tablets)
- Whether you have insurance (and if you know your plan’s copay/coinsurance)

Ways to potentially reduce cost:
- Check with your insurer or a pharmacy benefits manager for your exact copay/coinsurance.
- Look up cash price or discount programs (e.g., manufacturer discounts or third-party discount cards).
- Ask about the manufacturer’s patient assistance program for eligible patients.
- If cost is a barrier, discuss with your prescriber about alternatives or dosing adjustments that might be clinically reasonable within your regimen.

If you provide your country and dose, I can give a more specific ballpark range and point you to likely cost-saving options.